Hematologic Oncology Update cover image

Hematologic Oncology Update

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Oct 9, 2023
47:30
Creator website

Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma, moderated by Dr Neil Love.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner